Edwards Lifesciences Debt to Equity Ratio 2006-2018 | EW

Current and historical debt to equity ratio values for Edwards Lifesciences (EW) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Edwards Lifesciences debt/equity for the three months ending September 30, 2018 was 0.18.
Edwards Lifesciences Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2018-09-30 $0.59B $3.36B 0.18
2018-06-30 $0.59B $3.16B 0.19
2018-03-31 $0.46B $3.25B 0.14
2017-12-31 $0.44B $2.96B 0.15
2017-09-30 $1.03B $3.16B 0.33
2017-06-30 $1.02B $2.94B 0.35
2017-03-31 $0.85B $2.74B 0.31
2016-12-31 $0.82B $2.62B 0.31
2016-09-30 $0.60B $2.69B 0.22
2016-06-30 $0.60B $2.47B 0.24
2016-03-31 $0.60B $2.30B 0.26
2015-12-31 $0.60B $2.50B 0.24
2015-09-30 $0.61B $2.42B 0.25
2015-06-30 $0.60B $2.29B 0.26
2015-03-31 $0.60B $2.21B 0.27
2014-12-31 $0.60B $2.19B 0.27
2014-09-30 $0.60B $2.04B 0.29
2014-06-30 $0.60B $1.92B 0.31
2014-03-31 $0.73B $1.34B 0.54
2013-12-31 $0.59B $1.54B 0.38
2013-09-30 $0.53B $1.44B 0.37
2013-06-30 $0.23B $1.58B 0.14
2013-03-31 $0.19B $1.59B 0.12
2012-12-31 $0.19B $1.48B 0.13
2012-09-30 $0.18B $1.54B 0.11
2012-06-30 $0.19B $1.44B 0.13
2012-03-31 $0.18B $1.39B 0.13
2011-12-31 $0.15B $1.34B 0.11
2011-09-30 $0.18B $1.36B 0.13
2011-06-30 $0.18B $1.39B 0.13
2011-03-31 $0.00B $1.36B 0.00
2010-12-31 $0.00B $1.31B 0.00
2010-09-30 $0.00B $1.23B 0.00
2010-06-30 $0.18B $1.12B 0.16
2010-03-31 $0.13B $1.15B 0.11
2009-12-31 $0.09B $1.16B 0.08
2009-09-30 $0.10B $1.09B 0.09
2009-06-30 $0.11B $1.00B 0.11
2009-03-31 $0.12B $0.94B 0.13
2008-12-31 $0.18B $0.88B 0.20
2008-09-30 $0.20B $0.88B 0.23
2008-06-30 $0.14B $0.90B 0.16
2008-03-31 $0.06B $0.78B 0.08
2007-12-31 $0.06B $0.84B 0.07
2007-09-30 $0.06B $0.82B 0.07
2007-06-30 $0.06B $0.81B 0.07
2007-03-31 $0.23B $0.79B 0.29
2006-12-31 $0.24B $0.75B 0.32
2006-09-30 $0.25B $0.73B 0.35
2006-06-30 $0.28B $0.72B 0.39
2006-03-31 $0.29B $0.72B 0.40
2005-12-31 $0.32B $0.69B 0.46
2005-09-30 $0.25B $0.66B 0.38
2005-06-30 $0.27B $0.66B 0.41
2005-03-31 $0.28B $0.65B 0.43
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $34.272B $3.435B
Edwards Lifesciences Corporation provides products and technologies to treat late-stage cardiovascular disease. The Company's products include tissue replacement heart valves, heart valve repair products, hemodynamic monitoring devices, angioscopy equipment, oxygenators, and pharmaceuticals. Edwards Lifesciences Corporation is headquartered in Irvine, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $97.230B 22.66
Intuitive Surgical (ISRG) United States $58.499B 57.56
Fresenius Medical Care AG KGaA (FMS) Germany $21.277B 14.39
IDEXX Laboratories (IDXX) United States $16.813B 48.02
ABIOMED (ABMD) United States $14.400B 103.47
Hologic (HOLX) United States $12.390B 19.13
Teleflex (TFX) United States $11.791B 26.77
Varian Medical Systems (VAR) United States $11.069B 27.55
DexCom (DXCM) United States $10.930B 0.00
STERIS (STE) United Kingdom $9.670B 25.66
Masimo (MASI) United States $5.852B 37.94
LivaNova (LIVN) United Kingdom $4.662B 29.92
Globus Medical (GMED) United States $4.422B 27.72
Penumbra (PEN) United States $4.359B 263.19
Integra LifeSciences Holdings (IART) United States $4.192B 20.42
Wright Medical Group (WMGI) Netherlands $3.454B 0.00
Cantel Medical (CMD) United States $3.357B 33.12
Inogen (INGN) United States $2.840B 61.30
Integer Holdings (ITGR) United States $2.766B 23.15
Halyard Health (AVNS) United States $2.275B 20.50
Glaukos (GKOS) United States $2.240B 0.00
Tandem Diabetes Care (TNDM) United States $2.069B 0.00
OPKO Health (OPK) United States $1.909B 0.00
Mazor Robotics (MZOR) Israel $1.536B 0.00
Nevro (NVRO) United States $1.225B 0.00
Luminex (LMNX) United States $1.178B 42.63
Pacific Biosciences Of California (PACB) United States $1.118B 0.00
AxoGen (AXGN) United States $1.115B 0.00
Natus Medical (BABY) United States $1.088B 22.84
CryoLife (CRY) United States $1.075B 93.77
Orthofix (OFIX) United States $1.062B 30.66
Intersect ENT (XENT) United States $0.984B 0.00
Tactile Systems Technology (TCMD) United States $0.962B 153.21
Mesa Laboratories (MLAB) United States $0.811B 47.97
AngioDynamics (ANGO) United States $0.800B 27.99
Accelerate Diagnostics (AXDX) United States $0.708B 0.00
TransEnterix (TRXC) United States $0.657B 0.00
ViewRay (VRAY) United States $0.578B 0.00
Veracyte (VCYT) United States $0.532B 0.00
SI-BONE INC (SIBN) United States $0.486B 0.00
Sientra (SIEN) United States $0.457B 0.00
Quotient (QTNT) Switzerland $0.405B 0.00
OrthoPediatrics (KIDS) United States $0.402B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.379B 0.00
Neuronetics (STIM) United States $0.350B 0.00
Accuray (ARAY) United States $0.328B 0.00
Fluidigm (FLDM) United States $0.322B 0.00
SeaSpine Holdings (SPNE) United States $0.311B 0.00
Nuvectra (NVTR) United States $0.306B 0.00
IRadimed (IRMD) United States $0.298B 77.89
RTI Surgical (RTIX) United States $0.278B 43.80
GenMark Diagnostics (GNMK) United States $0.262B 0.00
CRH Medical (CRHM) Canada $0.259B 44.63
Helius Medical Technologies (HSDT) United States $0.255B 0.00
Corindus Vascular Robotics (CVRS) United States $0.243B 0.00
Pulse Biosciences (PLSE) United States $0.211B 0.00
T2 Biosystems (TTOO) United States $0.171B 0.00
Alphatec Holdings (ATEC) United States $0.114B 0.00
Ekso Bionics Holdings (EKSO) United States $0.106B 0.00
Ra Medical Systems (RMED) United States $0.102B 0.00
Sensus Healthcare (SRTS) United States $0.093B 0.00
Apollo Endosurgery (APEN) United States $0.089B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.087B 0.00
EDAP TMS (EDAP) France $0.069B 0.00
Biosig Technologies (BSGM) United States $0.067B 0.00
Second Sight Medical Products (EYES) United States $0.063B 0.00
Electromed (ELMD) United States $0.047B 22.64
Viveve Medical (VIVE) United States $0.046B 0.00
Xtant Medical Holdings (XTNT) United States $0.042B 0.00
Restoration Robotics (HAIR) United States $0.040B 0.00
OBALON THERPTCS (OBLN) United States $0.038B 0.00
Vermillion (VRML) United States $0.037B 0.00
ConforMIS (CFMS) United States $0.032B 0.00
Lianluo Smart (LLIT) China $0.029B 0.00
PAVmed (PAVM) United States $0.027B 0.00
Navidea Biopharmaceuticals (NAVB) United States $0.025B 0.00
DarioHealth (DRIO) Israel $0.022B 0.00
Dynatronics (DYNT) United States $0.021B 0.00
Titan Medical (TMDI) Canada $0.020B 0.00
Neovasc (NVCN) Canada $0.017B 0.00
American Shared Hospital Services (AMS) United States $0.014B 10.70
Bioanalytical Systems (BASI) United States $0.014B 0.00
Nanovibronix (NAOV) United States $0.013B 0.00
ENDRA Life Sciences (NDRA) United States $0.012B 0.00
Presbia (LENS) Ireland $0.010B 0.00
Micron Solutions (MICR) United States $0.009B 0.00
Allied Healthcare Products (AHPI) United States $0.008B 0.00
Avinger (AVGR) United States $0.008B 0.00
ReWalk Robotics (RWLK) Israel $0.007B 0.00
Cesca Therapeutics (KOOL) United States $0.007B 0.00
Atossa Genetics (ATOS) United States $0.007B 0.00
InspireMD (NSPR) Israel $0.007B 0.00
Microbot Medical (MBOT) United States $0.006B 0.00
Sunshine Heart Inc (CHFS) United States $0.005B 0.00
Amedica (SINT) United States $0.005B 0.00
EnteroMedics (RSLS) United States $0.000B 0.00
Check-Cap (CHEK) Israel $0.000B 0.00